Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations

[1]  O. Viklicky,et al.  SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[2]  Claudia C. Branco,et al.  Genetic variation in key genes associated with statin therapy in the Azores Islands (Portugal) healthy population , 2015, Annals of human biology.

[3]  P. Ridker,et al.  Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy. , 2013, American heart journal.

[4]  D. Ardissino,et al.  Genetic predisposition to atorvastatin‐induced myopathy: a case report , 2012, Journal of clinical pharmacy and therapeutics.

[5]  Ursula Matte,et al.  UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association? , 2012, Pediatric Research.

[6]  L Gong,et al.  The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy , 2012, Clinical pharmacology and therapeutics.

[7]  Guohong Deng,et al.  SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury. , 2012, Molecular medicine reports.

[8]  J. Krieger,et al.  SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia , 2012, European Journal of Clinical Pharmacology.

[9]  G. Dendramis.  [Interindividual differences in the response to statin therapy and gene polymorphisms related to myopathy during statin therapy]. , 2011, Giornale italiano di cardiologia.

[10]  P. Neuvonen,et al.  Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake , 2011, Pharmacological Reviews.

[11]  B. Melegh,et al.  Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. , 2011, Drug metabolism and pharmacokinetics.

[12]  R. Altman,et al.  PharmGKB very important pharmacogene: SLCO1B1. , 2010, Pharmacogenetics and genomics.

[13]  A. Balmforth,et al.  The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy , 2010, The Pharmacogenomics Journal.

[14]  A. Falus,et al.  Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies. , 2009, Blood cells, molecules & diseases.

[15]  M. Niemi,et al.  Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.

[16]  B. Melegh,et al.  Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples. , 2009, Pharmacogenomics.

[17]  C. Gui,et al.  Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. , 2008, Biochemistry.

[18]  R. Collins,et al.  SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.

[19]  R. Krauss,et al.  Pharmacogenomics of statin response , 2007, Current opinion in lipidology.

[20]  Mikko Niemi,et al.  Role of OATP transporters in the disposition of drugs. , 2007, Pharmacogenomics.

[21]  T. Parsons,et al.  Hungarian mtDNA population databases from Budapest and the Baranya county Roma , 2007, International Journal of Legal Medicine.

[22]  M. Niemi,et al.  Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans , 2007, Pharmaceutical Research.

[23]  Jeff P. Reeve,et al.  Mutation history of the roma/gypsies. , 2004, American journal of human genetics.

[24]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[25]  J. Nezu,et al.  Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. , 2002, The Journal of pharmacology and experimental therapeutics.

[26]  D. Gresham,et al.  Genetic studies of the Roma (Gypsies): a review , 2001, BMC Medical Genetics.

[27]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[28]  M. Hurles,et al.  Patterns of inter- and intra-group genetic diversity in the Vlax Roma as revealed by Y chromosome and mitochondrial DNA lineages , 2001, European Journal of Human Genetics.

[29]  C. Guglielmino,et al.  Probable ancestors of Hungarian ethnic groups: an admixture analysis , 2000 .

[30]  D. Keppler,et al.  A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[31]  V. Sasseville,et al.  A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2) , 1999, The Journal of Biological Chemistry.

[32]  F. Bernini,et al.  New insights into the pharmacodynamic and pharmacokinetic properties of statins. , 1999, Pharmacology & therapeutics.

[33]  G. Hardy.  MENDELIAN PROPORTIONS IN A MIXED POPULATION. , 1908 .